SCHEMBL25515437

SCHEMBL25515437

CCn1c2ccc(C(=O)CCC(C)C)cc2c2cc(C(=O)c3ccc(OC)cc3)ccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.45
MAPT P10636 6/20 0.45
ALDH1A1 P00352 4/20 0.45
HPGD P15428 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
PTGER4 P35408 1/20 0.44
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43
TUBB4B P68371 1/20 0.43
TUBB3 Q13509 1/20 0.43
TUBB2A Q13885 1/20 0.43
TUBB8 Q3ZCM7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25515435 0.87 TUBB4A (0.46) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL9459043 0.87 PTGER4 (0.55) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL25515429 0.86 CNR2 (0.45) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL23801739 0.82 KDM4E (0.50) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL23801240 0.81 KDM4E (0.57) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL23781994 0.81 MAPT (0.60) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL30000178 0.81 MAPT (0.60) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL22279401 0.78 KDM4E (0.40) KDM4EMAPTALDH1A1HPGDTUBB4A
SCHEMBL25515565 0.77 ELANE (0.49) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL25545442 0.76 MAPT (0.62) MAPTALDH1A1RAB9AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-05-11 US disclosed
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS OCIAD1, OCIAD2, OXER1 KDM4E 1857/4885MAPT 579/4885ALDH1A1 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.